The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Postoperative Nausea and Vomiting (PONV) Market Research Report 2025
Synopsis
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
The global Postoperative Nausea and Vomiting (PONV) market was valued at US$ 1913.5 million in 2023 and is anticipated to reach US$ 2955.4 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Postoperative Nausea and Vomiting (PONV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postoperative Nausea and Vomiting (PONV).
Report Scope
The Postoperative Nausea and Vomiting (PONV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Postoperative Nausea and Vomiting (PONV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Postoperative Nausea and Vomiting (PONV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Postoperative Nausea and Vomiting (PONV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
The global Postoperative Nausea and Vomiting (PONV) market was valued at US$ 1913.5 million in 2023 and is anticipated to reach US$ 2955.4 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Postoperative Nausea and Vomiting (PONV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postoperative Nausea and Vomiting (PONV).
Report Scope
The Postoperative Nausea and Vomiting (PONV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Postoperative Nausea and Vomiting (PONV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Postoperative Nausea and Vomiting (PONV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Postoperative Nausea and Vomiting (PONV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 NK-1 Receptor Antagonists
1.2.6 Non-pharmacologic Treatment
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2019-2030)
2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region
2.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2019-2024)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2025-2030)
2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics
2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2019-2024)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2019-2024)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2023
3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2019-2024)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2025-2030)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2019-2024)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2019-2030)
6.2 North America Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024)
6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2019-2030)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024)
7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2019-2030)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2019-2024)
8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2019-2030)
9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024)
9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2019-2030)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2019-2024)
10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Detail
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.1.5 Acacia Pharma Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Detail
11.4.2 Ani Pharmaceuticals Business Overview
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.4.5 Ani Pharmaceuticals Recent Development
11.5 Camurus
11.5.1 Camurus Company Detail
11.5.2 Camurus Business Overview
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.5.5 Camurus Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Detail
11.7.2 Helsinn Holding Business Overview
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.7.5 Helsinn Holding Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.8.5 Eisai Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.9.5 Merck Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2019-2024)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
